Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SNAPIN | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | TSC22D3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | C22orf31 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | GPCPD1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | SPRYD7 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | UBE2E1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | C16orf54 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | WBSCR22 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | POLR3C | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | NTMT1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |